Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription


1 Antimicrob Agents Chemother
4 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
2 Eur Respir J
1 Infect Immun
1 Int J Tuberc Lung Dis
2 J Clin Microbiol
2 Lancet Glob Health
2 PLoS Med
8 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. RIFAT D, Li SY, Ioerger T, Shah K, et al
    Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01948.
    PubMed         Abstract available

    Clin Infect Dis

  2. ZELNICK JR, Daftary A, Hwang C, Labar AS, et al
    Electronic dose monitoring identifies a high-risk subpopulation in the treatment of drug-resistant tuberculosis and HIV.
    Clin Infect Dis. 2020 Oct 14. pii: 5923372. doi: 10.1093/cid/ciaa1557.
    PubMed         Abstract available

  3. DUFFY D, Nemes E, Llibre A, Rouilly V, et al
    Immune profiling enables stratification of patients with active TB disease or M. tuberculosis infection.
    Clin Infect Dis. 2020 Oct 16. pii: 5924452. doi: 10.1093/cid/ciaa1562.
    PubMed         Abstract available

  4. KAKAIRE R, Kiwanuka N, Zalwango S, Sekandi JN, et al
    Excess Risk of Tuberculous Infection among Extra-Household Contacts of Tuberculosis Cases in an African City.
    Clin Infect Dis. 2020 Oct 16. pii: 5925052. doi: 10.1093/cid/ciaa1556.
    PubMed         Abstract available

  5. ZHENG X, Bao Z, Forsman LD, Hu Y, et al
    Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response.
    Clin Infect Dis. 2020 Oct 18. pii: 5929670. doi: 10.1093/cid/ciaa1569.
    PubMed         Abstract available

    Eur J Clin Microbiol Infect Dis

  6. KANG W, Du J, Yang S, Yu J, et al
    The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study.
    Eur J Clin Microbiol Infect Dis. 2020 Oct 22. pii: 10.1007/s10096-020-04077.
    PubMed         Abstract available

    Eur Respir J

  7. GUPTA N, Ish P, Gupta A, Malhotra N, et al
    A profile of a retrospective cohort of 22 patients of COVID-19 with active/treated tuberculosis.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03408-2020.

  8. KWON YS, Jeon D, Kang H, Yim JJ, et al
    Concurrent Use of Bedaquiline and Delamanid for the Treatment of Fluoroquinolone-resistant Multidrug-resistant Tuberculosis: A Nationwide Cohort Study in South Korea.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03026-2020.

    Infect Immun

  9. VORKAS CK, Levy O, Skular M, Li K, et al
    Efficient 5-OP-RU-induced enrichment of Mucosal-associated invariant T cells in the murine lung does not enhance control of aerosol Mycobacterium tuberculosis infection.
    Infect Immun. 2020 Oct 19. pii: IAI.00524-20. doi: 10.1128/IAI.00524.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  10. BASHAM CA, Romanowski K, Johnston JC
    Cardiovascular disease: the forgotten cousin of post-TB health?
    Int J Tuberc Lung Dis. 2020;24:466-467.

    J Clin Microbiol

  11. SMITH C, Halse TA, Shea J, Modestil H, et al
    Assessing Nanopore sequencing for clinical diagnostics: A comparison of NGS methods for Mycobacterium tuberculosis.
    J Clin Microbiol. 2020 Oct 14. pii: JCM.00583-20. doi: 10.1128/JCM.00583.
    PubMed         Abstract available

  12. MEYER AJ, Ochom E, Turimumahoro P, Byanyima P, et al
    C-Reactive Protein for Active Tuberculosis Among Inpatients without HIV in Uganda: A Diagnostic Accuracy Study.
    J Clin Microbiol. 2020 Oct 21. pii: JCM.02162-20. doi: 10.1128/JCM.02162.
    PubMed         Abstract available


  13. Tuberculosis.
    JAMA. 2020;324:1575.

    Lancet Glob Health

  14. DOGAR O, Keding A, Gabe R, Marshall AM, et al
    Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet Glob Health. 2020;8:e1408-e1417.
    PubMed         Abstract available

  15. KEDDY KH, Migliori GB, Van Der Walt M
    Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis.
    Lancet Glob Health. 2020;8:e1357-e1358.

    PLoS Med

  16. KAVANAGH MM, Gostin LO, Stephens J
    Tuberculosis, human rights, and law reform: Addressing the lack of progress in the global tuberculosis response.
    PLoS Med. 2020;17:e1003324.
    PubMed         Abstract available

  17. ABDULLAHI SA, Smelyanskaya M, John S, Adamu HI, et al
    Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
    PLoS Med. 2020;17:e1003218.
    PubMed         Abstract available

    PLoS One

  18. KAGUJJE M, Chilukutu L, Somwe P, Mutale J, et al
    Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.
    PLoS One. 2020;15:e0237931.
    PubMed         Abstract available

  19. MERID MW, Muluneh AG, Yenit MK, Kassa GM, et al
    Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.
    PLoS One. 2020;15:e0240564.
    PubMed         Abstract available

  20. VELAYUTHAM B, Jayabal L, Watson B, Jagadeesan S, et al
    Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    PLoS One. 2020;15:e0240594.
    PubMed         Abstract available

  21. MBUTHIA GW, Nyamogoba HDN, Chiang SS, McGarvey ST, et al
    Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study.
    PLoS One. 2020;15:e0240457.
    PubMed         Abstract available

  22. BROOKS MB, Mitnick CD, Manjourides J
    Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
    PLoS One. 2020;15:e0240297.
    PubMed         Abstract available

  23. NGUIPDOP-DJOMO P, Rodrigues LC, Abubakar I, Mangtani P, et al
    Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
    PLoS One. 2020;15:e0240879.
    PubMed         Abstract available

  24. TAN C, Kallon II, Colvin CJ, Grant AD, et al
    Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
    PLoS One. 2020;15:e0241039.
    PubMed         Abstract available

  25. TING NCH, El-Turk N, Chou MSH, Dobler CC, et al
    Patient-perceived treatment burden of tuberculosis treatment.
    PLoS One. 2020;15:e0241124.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  26. CHENG Q, Trangucci R, Nelson KN, Fu W, et al
    Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations.
    Proc Natl Acad Sci U S A. 2020 Oct 19. pii: 2008336117.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.